美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 8 条
共 1 页，当前第 1 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| RETEVMO |
213246 |
001 |
NDA |
SELPERCATINIB |
CAPSULE;ORAL |
40MG |
Yes
|
No
|
2020/05/08
|
2020/05/08
|
LOXO ONCOL ELI LILLY |
Prescription |
| RETEVMO |
213246 |
002 |
NDA |
SELPERCATINIB |
CAPSULE;ORAL |
80MG |
Yes
|
Yes
|
2020/05/08
|
2020/05/08
|
LOXO ONCOL ELI LILLY |
Prescription |
| RETEVMO |
218160 |
001 |
NDA |
SELPERCATINIB |
TABLET;ORAL |
40MG |
Yes
|
No
|
2024/04/10
|
2024/04/10
|
LOXO ONCOL ELI LILLY |
Prescription |
| RETEVMO |
218160 |
002 |
NDA |
SELPERCATINIB |
TABLET;ORAL |
80MG |
Yes
|
No
|
2024/04/10
|
2024/04/10
|
LOXO ONCOL ELI LILLY |
Prescription |
| RETEVMO |
218160 |
003 |
NDA |
SELPERCATINIB |
TABLET;ORAL |
120MG |
Yes
|
No
|
2024/04/10
|
2024/04/10
|
LOXO ONCOL ELI LILLY |
Prescription |
| RETEVMO |
218160 |
004 |
NDA |
SELPERCATINIB |
TABLET;ORAL |
160MG |
Yes
|
Yes
|
2024/04/10
|
2024/04/10
|
LOXO ONCOL ELI LILLY |
Prescription |
| RETEVMO |
218160 |
005 |
NDA |
SELPERCATINIB |
CAPSULE;ORAL |
40MG |
No
|
No
|
2024/04/10
|
--
|
LOXO ONCOL ELI LILLY |
Prescription |
| RETEVMO |
218160 |
006 |
NDA |
SELPERCATINIB |
CAPSULE;ORAL |
80MG |
No
|
No
|
2024/04/10
|
--
|
LOXO ONCOL ELI LILLY |
Prescription |